Literature DB >> 10590265

Expression profile of active genes in mouse lymph node high endothelial cells.

D Izawa1, T Tanaka, K Saito, H Ogihara, T Usui, S Kawamoto, K Matsubara, K Okubo, M Miyasaka.   

Abstract

High endothelial venules (HEV) allow rapid and selective lymphocyte trafficking from the blood into secondary lymphoid tissues. Here we report the expression profile of active genes in mouse high endothelial cells (HEC). HEC were first purified from mouse lymph nodes (LN) by magnetic cell sorting with MECA-79 mAb and a 3'-directed cDNA library that faithfully represents the composition of mRNA was constructed. A total of 1495 cDNA sequences were obtained from randomly selected clones. Based on their sequence identity, they were grouped into 754 different species [gene signatures (GS)] of which 335 GS were identified in GenBank. Among the previously identified genes, expression of several endothelial cell surface molecules including endoglin and ICAM-1 was detected in HEC. Comparison of the gene expression profile with that of purified CD31(+) flat endothelial cells identified several molecules, such as KC chemokine and Duffy antigen/receptor for chemokines, that are known to be selectively expressed in activated endothelial cells or post-capillary venules. Interestingly, mac25/TAF, which is known to be expressed specifically in tumor vessels and implicated in the regulation of cell adhesion, was highly and selectively expressed in HEC in mouse LN, suggesting that it may participate in regulating HEC-specific functions. Comparison with the expression profiles obtained from 35 different cell types showed at least 22 GS that were apparently specific to HEC. Our results illustrate the expression differences between HEC and CD31(+) flat endothelial cells, and will be useful for the identification and characterization of genes specific for HEC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10590265     DOI: 10.1093/intimm/11.12.1989

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules.

Authors:  Espen S Baekkevold; Myriam Roussigné; Takeshi Yamanaka; Finn-Eirik Johansen; Frode L Jahnsen; François Amalric; Per Brandtzaeg; Monique Erard; Guttorm Haraldsen; Jean-Philippe Girard
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

2.  Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions.

Authors:  Tae Nakasaki; Toshiyuki Tanaka; Shinichi Okudaira; Michi Hirosawa; Eiji Umemoto; Kazuhiro Otani; Soojung Jin; Zhongbin Bai; Haruko Hayasaka; Yoshinori Fukui; Katsuyuki Aozasa; Naoya Fujita; Takashi Tsuruo; Keiichi Ozono; Junken Aoki; Masayuki Miyasaka
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

3.  Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs.

Authors:  Hidenobu Kanda; Rebecca Newton; Russell Klein; Yuka Morita; Michael D Gunn; Steven D Rosen
Journal:  Nat Immunol       Date:  2008-03-09       Impact factor: 25.606

4.  GFAP and desmin expression in lymphatic tissues leads to difficulties in distinguishing between glial and stromal cells.

Authors:  Hauke Simon Günther; Stephan Henne; Jasmin Oehlmann; Julia Urban; Desiree Pleizier; Nicklas Renevier; Christian Lohr; Clemens Wülfing
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

5.  Nepmucin, a novel HEV sialomucin, mediates L-selectin-dependent lymphocyte rolling and promotes lymphocyte adhesion under flow.

Authors:  Eiji Umemoto; Toshiyuki Tanaka; Hidenobu Kanda; Soojung Jin; Kazuo Tohya; Kazuhiro Otani; Takahiro Matsutani; Masanori Matsumoto; Yukihiko Ebisuno; Myoung Ho Jang; Minoru Fukuda; Takako Hirata; Masayuki Miyasaka
Journal:  J Exp Med       Date:  2006-06-05       Impact factor: 14.307

6.  Dynamic changes in endothelial cell adhesion molecule nepmucin/CD300LG expression under physiological and pathological conditions.

Authors:  Eiji Umemoto; Akira Takeda; Soojung Jin; Zhijuan Luo; Naoki Nakahogi; Haruko Hayasaka; Chun Man Lee; Toshiyuki Tanaka; Masayuki Miyasaka
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

Review 7.  High endothelial venules (HEVs) in immunity, inflammation and cancer.

Authors:  Lucas Blanchard; Jean-Philippe Girard
Journal:  Angiogenesis       Date:  2021-05-06       Impact factor: 9.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.